Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults
NCT ID: NCT01155076
Last Updated: 2013-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
116 participants
INTERVENTIONAL
2010-07-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitality product
Proprietary blend of ginseng, cordyceps, and pomegranate
Vitality Product
Proprietary blend of ginseng, cordyceps, and pomegranate taken twice a day for 8 weeks
Placebo
Placebo
Placebo
Placebo taken twice a day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitality Product
Proprietary blend of ginseng, cordyceps, and pomegranate taken twice a day for 8 weeks
Placebo
Placebo taken twice a day for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed Informed Consent
* BMI between 19 and 30 kg/m2
* Normotensive, defined as systolic blood pressure 90-140 mmHg and diastolic blood pressure 50-90 mmHg
Exclusion Criteria
* Self-reported chronic condition that may affect subject safety (e.g. diabetes, cardiovascular disease) or significantly impact product effectiveness (e.g. chronic fatigue)
* Pregnancy/suspected pregnancy, breastfeeding
* Antihypertensive medication use
* Allergies to any supplement ingredients
* Consumption of more than 600mg caffeine from any source per day
* Consumption of "energy drinks" (e.g. Red Bull, Monster) or any herbal supplement known to affect energy levels
* Known iron anemia
* Medically treated for insomnia
* Medically treated for depression
* Taking medications known to affect energy, e.g. thyroid medication
* Tobacco user
* Planned surgical procedure in next 2 months
* Participating in another clinical (medical or nutritional) study or likely to enroll in another medical or nutritional study
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sprim Advanced Life Sciences
OTHER
Pharmanex
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John McGettigan, MD
Role: PRINCIPAL_INVESTIGATOR
Quality of Life Medical & Research Center, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Quality of Life Medical and Research Center
Tucson, Arizona, United States
Ridgeview Chaska Medical Plaza
Chaska, Minnesota, United States
West Houston Clinical Research Services
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-SUS-03-NU-01
Identifier Type: -
Identifier Source: org_study_id